Clinical Trial Update: MSC for Occlusive Disease of the Kidney [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating mesenchymal stem cells for occlusive disease of the kidney has completed, studying atherosclerotic renal artery stenosis, ischemic neph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Renal Artery Stenosis
• Ischemic Nephropathy
• Renovascular Hypertension

Drugs mentioned

• Mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Mayo Clinic | Conditions: Atherosclerotic Renal Artery Stenosis, Ischemic Nephropathy | Phase 1 | Status: COMPLETED